Cost-effectiveness of treating pediatric drug-resistant epilepsy

Cannabis-based treatments may reduce seizures among children with drug-resistant epilepsy, but are these treatments cost-effective? 

Economic evaluations of cannabis treatments are needed, and they should address issues including weight-gain over time, switching or discontinuation of treatments, the effectiveness of interventions, and long-term success, beyond the duration of available clinical studies.

This paper is also stored here:    inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDCost-effectiveness of treating pediatric drug-resistant epilepsy

Related Posts